These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33539319)

  • 1. MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach.
    Varlamov EV; Langlois F; Vila G; Fleseriu M
    Eur J Endocrinol; 2021 Apr; 184(5):R207-R224. PubMed ID: 33539319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
    Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening Pneumocystis jiroveci pneumonia following treatment of severe Cushing's syndrome.
    Oosterhuis JK; van den Berg G; Monteban-Kooistra WE; Ligtenberg JJ; Tulleken JE; Meertens JH; Zijlstra JG
    Neth J Med; 2007 Jun; 65(6):215-7. PubMed ID: 17587649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?
    Koracevic G; Stojkovic M; Lovic D; Pavlovic M; Kostic T; Kutlesic M; Micic S; Koracevic M; Djordjevic M
    Curr Vasc Pharmacol; 2020; 18(1):12-24. PubMed ID: 30289080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis pneumonia during medicamentous treatment of Cushing's syndrome--a description of two cases.
    Gabalec F; Zavrelová A; Havel E; Cerman J; Radocha J; Svilias I; Cáp J
    Acta Medica (Hradec Kralove); 2011; 54(3):127-30. PubMed ID: 22250484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic disease in hypercortisolism.
    Capatina C; Fleseriu M
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):330-336. PubMed ID: 33741780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal pneumocystis jirovecii pneumonia in a case of ectopic Cushing's syndrome due to neuroendocrine carcinoma of the kidney.
    Arlt A; Harbeck B; Anlauf M; Alkatout I; Klöppel G; Fölsch UR; Bewig B; Mönig H
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):515-9. PubMed ID: 18523920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
    van Haalen FM; Kaya M; Pelsma ICM; Dekkers OM; Biermasz NR; Cannegieter SC; Huisman MV; van Vlijmen BJM; Feelders RA; Klok FA; Pereira AM;
    Orphanet J Rare Dis; 2022 May; 17(1):178. PubMed ID: 35505430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent thromboembolism as a hallmark of Cushing's syndrome.
    La Brocca A; Terzolo M; Pia A; Paccotti P; De Giuli P; Angeli A
    J Endocrinol Invest; 1997 Apr; 20(4):211-4. PubMed ID: 9211128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and Life-threatening Complications in Cushing Syndrome: Prevalence, Predictors, and Mortality.
    Schernthaner-Reiter MH; Siess C; Micko A; Zauner C; Wolfsberger S; Scheuba C; Riss P; Knosp E; Kautzky-Willer A; Luger A; Vila G
    J Clin Endocrinol Metab; 2021 Apr; 106(5):e2035-e2046. PubMed ID: 33517433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipokines and cardiovascular risk in Cushing's syndrome.
    Valassi E; Biller BM; Klibanski A; Misra M
    Neuroendocrinology; 2012; 95(3):187-206. PubMed ID: 22057123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
    Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome.
    Boscaro M; Sonino N; Scarda A; Barzon L; Fallo F; Sartori MT; Patrassi GM; Girolami A
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3662-6. PubMed ID: 12161492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
    Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
    Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of atherosclerosis in patients with Cushing's syndrome: a meta-analysis of literature studies.
    Lupoli R; Ambrosino P; Tortora A; Barba L; Lupoli GA; Di Minno MN
    Ann Med; 2017 May; 49(3):206-216. PubMed ID: 27763781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical remission of Cushing's syndrome reduces cardiovascular risk.
    Terzolo M; Allasino B; Pia A; Peraga G; Daffara F; Laino F; Ardito A; Termine A; Paccotti P; Berchialla P; Migliaretti G; Reimondo G
    Eur J Endocrinol; 2014 Jul; 171(1):127-36. PubMed ID: 24801586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.
    Schernthaner-Reiter MH; Siess C; Gessl A; Scheuba C; Wolfsberger S; Riss P; Knosp E; Luger A; Vila G
    Endocrine; 2019 Apr; 64(1):157-168. PubMed ID: 30467627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A venous thromboembolism risk assessment model for patients with Cushing's syndrome.
    Zilio M; Mazzai L; Sartori MT; Barbot M; Ceccato F; Daidone V; Casonato A; Saggiorato G; Noventa F; Trementino L; Prandoni P; Boscaro M; Arnaldi G; Scaroni C
    Endocrine; 2016 May; 52(2):322-32. PubMed ID: 26113424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.